Download presentation
Presentation is loading. Please wait.
1
Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
<br /><br />E1308:<br />A Phase II Trial of Induction Chemotherapy Followed by Cetuximab with Low Dose vs. Standard Dose IMRT in Patients with HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
2
Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
Disclosures Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
3
Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
Slide 3 Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
4
Background: HPV+ OP SCCa
Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
5
Rationale: Cetuximab based Induction CT
Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
6
Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
Slide 6 Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
7
Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
Endpoints Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
8
Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
Statistics Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
9
Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
Results Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
10
Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
Slide 10 Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
11
Results: Acute Toxicity
Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
12
Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
Late Toxicity Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
13
Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
Response: Induction Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
14
Response: Following Cetux/IMRT
Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
15
Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
Endpoint: 2yr PFS and OS Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
16
Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
PFS and Survival: Dose Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
17
Low Dose: T stage and N stage
Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
18
Smoking: PFS and Survival
Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
19
Best Outcome: <T4, T1-N2b, <10 pk-yr
Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
20
First Failure Patterns: Low-dose pts
Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
21
Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
Summary Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
22
Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
Conclusions Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
23
Designed and conducted by:
Presented By Anthony Cmelak at 2014 ASCO Annual Meeting
Similar presentations
